GBCS
SELECTIS HEALTH, INC.
-0.05 (-0.87%)5.69USD400成交股數17.5M市值1.4本益比(近四季)0.5股價營收比-54.7%營收年增(近四季)–下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | 4.7M-55% | 7.3M-30% | 9.7M-3% | 10.8M+13% | 10.4M+10% | 10.5M+14% | 10.0M+11% | 9.6M+7% | 9.5M | 9.2M | 9.0M | 8.9M |
| 營業成本 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 研發費用 | – | – | – | – | – | – | – | – | – | – | – | – |
| 銷售管理費用 | 2.1M | 2.1M | 2.1M | 2.1M | 2.2M | 2.4M | 2.4M | 2.4M | 2.2M | 2.5M | 3.1M | 2.2M |
| 營業利益 | −2.1M+367% | −1.3M+199% | −396K-66% | −297K-61% | −450K-35% | −422K-86% | −1.2M-51% | −764K-52% | −696K | −3.0M | −2.4M | −1.6M |
| 營業利益率 | -44.5% | -17.3% | -4.1% | -2.7% | -4.3% | -4.0% | -11.7% | -8.0% | -7.3% | -32.5% | -26.7% | -17.7% |
| 稅後淨利 | 8.1M-2737% | 6.5M-1095% | −804K-50% | 752K-5% | −308K-70% | −656K-82% | −1.6M-29% | 794K-138% | −1.0M | −3.6M | −2.3M | −2.1M |
| 淨利率 | 171.9% | 89.5% | -8.3% | 6.9% | -3.0% | -6.3% | -16.0% | 8.3% | -10.9% | -39.5% | -25.0% | -23.5% |
| 稀釋 EPS | 2.35-2450% | 1.90-964% | -0.26-50% | 0.24-8% | -0.10-71% | -0.22-82% | -0.52-30% | 0.26-138% | -0.34 | -1.20 | -0.74 | -0.69 |
| 稀釋股數 | 3.5M | 3.4M | 3.1M | 3.1M | 3.1M | 3.1M | 3.1M | 3.1M | 3.1M | 3.1M | 3.1M | 3.1M |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 7.7M | 1.3M | 1.0M | 417K | 560K | 1.3M | 1.8M | 3.2M | 1.3M | 1.5M | 2.0M | 626K |
| 應收帳款 | 1.4M | 2.5M | 2.3M | 3.2M | 3.0M | 2.9M | 1.9M | 2.2M | 1.8M | 2.1M | 2.0M | 2.6M |
| 存貨 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總資產 | 31.5M | 30.0M | 32.6M | 33.3M | 33.6M | 34.5M | 33.9M | 36.7M | 39.6M | 40.7M | 42.3M | 46.9M |
| 有息負債 | 11.6M | 13.3M | 13.4M | 18.5M | 18.7M | 19.0M | 18.5M | 21.6M | 25.1M | 25.2M | 25.9M | 26.1M |
| 總負債 | 23.5M | 30.2M | 39.2M | 38.9M | 40.0M | 40.6M | 38.8M | 39.9M | 43.6M | 43.6M | 41.7M | 44.1M |
| 股東權益 | 8.0M | −143K | −6.6M | −5.7M | −6.8M | −6.5M | −4.8M | −3.2M | −4.0M | −3.0M | 677K | 2.9M |
| 負債比 | 74.6% | 100.5% | 120.3% | 117.0% | 119.0% | 117.6% | 114.2% | 108.8% | 110.1% | 107.3% | 98.4% | 93.9% |
| 淨現金(現金 − 有息負債) | −3.9M | −12.0M | −12.4M | −18.1M | −18.1M | −17.7M | −16.6M | −18.4M | −23.8M | −23.7M | −24.0M | −25.5M |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | −2.3M-321% | – | – | – | 1.0M | – | – | 249K | – | – | – |
| 資本支出 | – | 377K | – | – | – | 219K | – | – | 117K | – | – | – |
| 自由現金流 | – | −2.7M-427% | – | – | – | 816K | – | – | 133K | – | – | – |
| 折舊攤銷 | 229K | 333K | – | – | 363K | 363K | 374K | 410K | 424K | 431K | 358K | 439K |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | -36.6% | – | – | – | 7.8% | – | – | 1.4% | – | – | – |
營收拆解 2025 年度 10-K 的分部揭露 · 年增對前一年度
產品／服務2025 年度 · 41.4M
| Health Care | 41.4M | 99.8% | +5.6% |
|---|---|---|---|
| Management Fee Revenue | 66K | 0.2% | – |
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | 41.4M | +4.9% | −1.0M | -2.5% | -0.34 | 1.4M |
| FY2024 | 39.5M | +7.4% | −2.4M | -6.1% | -0.80 | −1.9M |
| FY2023 | 36.8M | -9.4% | −4.0M | -10.8% | -1.31 | 507K |
| FY2022 | 40.6M | +38.6% | −2.4M | -5.9% | -0.79 | −528K |
| FY2021 | 29.3M | +39.9% | −2.3M | -7.7% | -0.82 | −791K |
| FY2020 | 20.9M | +202.0% | 3.0M | 14.1% | 0.95 | 1.7M |
| FY2019 | 6.9M | +91.3% | −862K | -12.4% | -0.03 | −800K |
| FY2018 | 3.6M | – | −2.0M | -55.0% | -0.08 | −655K |